During the past decade, Intercity Gastroenterology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intercity Gastroenterology" #1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Intercity Gastroenterology" are "Colorectal Cancer" (1 trials) and "Non-Alcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Intercity Gastroenterology" in a lesser frequency.

Most popular intervention types in "Intercity Gastroenterology" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "EDP-305 1.5 mg" (1 trials), "EDP-305 2 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Intercity Gastroenterology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Intercity Gastroenterology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Intercity Gastroenterology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Intercity Gastroenterology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".